Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sutherland

Showing results (401-410 of 613) with videos related to

Pageof 62
Sort By:
Histopathology|March 29, 2008
Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesionsW A Cooper, M R J Kohonen-Corish, C Chan, et al.
Brain and Behavior|November 10, 2012
Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosisBruce J Lerman, Eric P Hoffman, Margaret L Sutherland, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancerEleanor Y M Sum, Davendra Segara, Belinda Duscio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
Electrophoresis|March 1, 1994
Purification and identification of tyrosine-phosphorylated proteins from B lymphocytes stimulated through the antigen receptorM R Gold, T Yungwirth, C L Sutherland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|November 26, 2009
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalC A Barton, B S Gloss, W Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Cyclin E expression and outcome in pancreatic ductal adenocarcinomaDavid A Skalicky, James G Kench, Davendra Segara, et al.
Plos One|March 10, 2009
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroupM Chehani Alles, Margaret Gardiner-Garden, David J Nott, et al.
Pageof 62

Showing results (401-410 of 613) with videos related to

Sort By:
Pageof 62
Histopathology|March 29, 2008
Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesionsW A Cooper, M R J Kohonen-Corish, C Chan, et al.
Brain and Behavior|November 10, 2012
Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosisBruce J Lerman, Eric P Hoffman, Margaret L Sutherland, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancerEleanor Y M Sum, Davendra Segara, Belinda Duscio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
Electrophoresis|March 1, 1994
Purification and identification of tyrosine-phosphorylated proteins from B lymphocytes stimulated through the antigen receptorM R Gold, T Yungwirth, C L Sutherland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|November 26, 2009
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalC A Barton, B S Gloss, W Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Cyclin E expression and outcome in pancreatic ductal adenocarcinomaDavid A Skalicky, James G Kench, Davendra Segara, et al.
Plos One|March 10, 2009
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroupM Chehani Alles, Margaret Gardiner-Garden, David J Nott, et al.
Pageof 62